{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PEG-PCL", "apoptosis", "folic acid", "glioma", "luteolin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31571861", "DateCompleted": {"Year": "2019", "Month": "11", "Day": "20"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "09", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S214585"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2019"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Delivery luteolin with folacin-modified nanoparticle for glioma therapy.", "Pagination": {"StartPage": "7515", "EndPage": "7531", "MedlinePgn": "7515-7531"}, "Abstract": {"AbstractText": ["Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability.", "In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo.", "When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL.", "These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention."], "CopyrightInformation": "\u00a9 2019 Wu et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China."}], "LastName": "Wu", "ForeName": "Cong", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China."}], "LastName": "Xu", "ForeName": "Qian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China."}], "LastName": "Chen", "ForeName": "Xinyue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China."}], "LastName": "Liu", "ForeName": "Jiagang", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Micelles"}, {"RegistryNumber": "0", "NameOfSubstance": "Platelet Endothelial Cell Adhesion Molecule-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyesters"}, {"RegistryNumber": "0", "NameOfSubstance": "Proliferating Cell Nuclear Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "methoxy poly(ethylene glycol-co-epsilon-caprolactone)"}, {"RegistryNumber": "3WJQ0SDW1A", "NameOfSubstance": "Polyethylene Glycols"}, {"RegistryNumber": "935E97BOY8", "NameOfSubstance": "Folic Acid"}, {"RegistryNumber": "KUX1ZNC9J2", "NameOfSubstance": "Luteolin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Drug Liberation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Folic Acid"}, {"QualifierName": ["blood supply", "drug therapy"], "DescriptorName": "Glioma"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacokinetics", "therapeutic use"], "DescriptorName": "Luteolin"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": [], "DescriptorName": "Micelles"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": ["chemistry", "ultrastructure"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["metabolism"], "DescriptorName": "Platelet Endothelial Cell Adhesion Molecule-1"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polyesters"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polyethylene Glycols"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proliferating Cell Nuclear Antigen"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}], "CoiStatement": "The authors report no conflict of interest in this study."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alcantara Llaguno SR, Wang Z, Sun D, et al. Adult lineage-restricted CNS progenitors specify distinct glioblastoma subtypes. Cancer Cell. 2015;28(4):429\u2013440. doi:10.1016/j.ccell.2015.09.007", "ArticleIdList": ["10.1016/j.ccell.2015.09.007", "PMC4607935", "26461091"]}, {"Citation": "Zhao HF, Wang J, Shao W, et al. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development. Mol Cancer. 2017;16(1):100. doi:10.1186/s12943-017-0670-3", "ArticleIdList": ["10.1186/s12943-017-0670-3", "PMC5463420", "28592260"]}, {"Citation": "Thomas AA, Brennan CW, DeAngelis LM, Omuro AM. Emerging therapies for glioblastoma. JAMA Neurol. 2014;71(11):1437\u20131444. doi:10.1001/jamaneurol.2014.1701", "ArticleIdList": ["10.1001/jamaneurol.2014.1701", "25244650"]}, {"Citation": "Wang F, Wang AY, Chesnelong C, et al. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways. Oncogene. 2018;37(3):286\u2013301.", "ArticleIdList": ["PMC5799773", "28925404"]}, {"Citation": "Tian R, Wang J, Yan H, et al. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Oncogene. 2017;36(42):5861\u20135873.", "ArticleIdList": ["PMC5658672", "28628119"]}, {"Citation": "Zhong JD, Feng Y, Li HM, Xia XS, Li RT. A new flavonoid glycoside from Elsholtzia bodinieri. Nat Prod Res. 2016;30(20):2278\u20132284.", "ArticleIdList": ["27093392"]}, {"Citation": "Al-Qudah MA, Otoom NK, Al-Jaber HI, et al. New flavonol glycoside from Scabiosa prolifera L. aerial parts with in vitro antioxidant and cytotoxic activities. Nat Prod Res. 2017;31(24):2865\u20132874.", "ArticleIdList": ["28338344"]}, {"Citation": "He Y, Xia Z, Yu D, et al. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice. Int Immunopharmacol. 2019;68:171\u2013178.", "ArticleIdList": ["30641432"]}, {"Citation": "Xiao N, Mei F, Sun Y, Pan G, Liu B, Liu K. Quercetin, luteolin, and epigallocatechin gallate promote glucose disposal in adipocytes with regulation of AMP-activated kinase and/or sirtuin 1 activity. Planta Med. 2014;80(12):993\u20131000.", "ArticleIdList": ["25057854"]}, {"Citation": "Maatouk M, Mustapha N, Mokdad-Bzeouich I, et al. Thermal treatment of luteolin-7-O-beta-glucoside improves its immunomodulatory and antioxidant potencies. Cell Stress Chaperones. 2017;22(6):775\u2013785. doi:10.1007/s12192-017-0808-7", "ArticleIdList": ["10.1007/s12192-017-0808-7", "PMC5655366", "28578499"]}, {"Citation": "Wang L, Li W, Lin M, et al. Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis. Carcinogenesis. 2014;35(10):2321\u20132330. doi:10.1093/carcin/bgu145", "ArticleIdList": ["10.1093/carcin/bgu145", "PMC6276919", "25023990"]}, {"Citation": "Tang L, Li Y, Chen WY, et al. Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9. Pharm Res. 2014;31(4):847\u2013860. doi:10.1007/s11095-013-1207-0", "ArticleIdList": ["10.1007/s11095-013-1207-0", "24092055"]}, {"Citation": "Liu H, Zeng Z, Wang S, et al. Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9. Cancer Biol Ther. 2017;18(12):990\u2013999. doi:10.1080/15384047.2017.1394542", "ArticleIdList": ["10.1080/15384047.2017.1394542", "PMC5718784", "29173024"]}, {"Citation": "Cook MT, Liang Y, Besch-Williford C, Hyder SM. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells. Breast Cancer. 2017;9:9\u201319.", "ArticleIdList": ["PMC5207335", "28096694"]}, {"Citation": "Sonoki H, Tanimae A, Endo S, et al. Kaempherol and luteolin decrease claudin-2 expression mediated by inhibition of STAT3 in lung adenocarcinoma A549 cells. Nutrients. 2017;9:6. doi:10.3390/nu9060597", "ArticleIdList": ["10.3390/nu9060597", "PMC5490576", "28608828"]}, {"Citation": "Kwon EJ, Skalak M, Lo Bu R, Bhatia SN. Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries. ACS Nano. 2016;10(8):7926\u20137933. doi:10.1021/acsnano.6b03858", "ArticleIdList": ["10.1021/acsnano.6b03858", "PMC5896006", "27429164"]}, {"Citation": "Saraiva C, Praca C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Controlled Release. 2016;235:34\u201347. doi:10.1016/j.jconrel.2016.05.044", "ArticleIdList": ["10.1016/j.jconrel.2016.05.044", "27208862"]}, {"Citation": "Anraku Y, Kuwahara H, Fukusato Y, et al. Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat Commun. 2017;8(1):1001. doi:10.1038/s41467-017-00952-3", "ArticleIdList": ["10.1038/s41467-017-00952-3", "PMC5645389", "29042554"]}, {"Citation": "Aslund AKO, Berg S, Hak S, et al. Nanoparticle delivery to the brain\u2013by focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. J Controlled Release. 2015;220(Pt A):287\u2013294. doi:10.1016/j.jconrel.2015.10.047", "ArticleIdList": ["10.1016/j.jconrel.2015.10.047", "26518721"]}, {"Citation": "Ye D, Raghnaill MN, Bramini M, et al. Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale. 2013;5(22):11153\u201311165. doi:10.1039/c3nr02905k", "ArticleIdList": ["10.1039/c3nr02905k", "24077327"]}, {"Citation": "Jones SK, Sarkar A, Feldmann DP, Hoffmann P, Merkel OM. Revisiting the value of competition assays in folate receptor-mediated drug delivery. Biomaterials. 2017;138:35\u201345. doi:10.1016/j.biomaterials.2017.05.034", "ArticleIdList": ["10.1016/j.biomaterials.2017.05.034", "PMC5522709", "28551461"]}, {"Citation": "Xu L, Bai Q, Zhang X, Yang H. Folate-mediated chemotherapy and diagnostics: an updated review and outlook. J Controlled Release. 2017;252:73\u201382. doi:10.1016/j.jconrel.2017.02.023", "ArticleIdList": ["10.1016/j.jconrel.2017.02.023", "PMC5479736", "28235591"]}, {"Citation": "Liu X, Wang B, Li Y, et al. Powerful anticolon tumor effect of targeted gene immunotherapy using folate-modified nanoparticle delivery of CCL19 to activate the immune system. ACS Cent Sci. 2019;5(2):277\u2013289. doi:10.1021/acscentsci.8b00688", "ArticleIdList": ["10.1021/acscentsci.8b00688", "PMC6396391", "30834316"]}, {"Citation": "Gao X, Wang S, Wang B, et al. Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations. Biomaterials. 2015;53:646\u2013658. doi:10.1016/j.biomaterials.2015.02.108", "ArticleIdList": ["10.1016/j.biomaterials.2015.02.108", "25890760"]}, {"Citation": "Cao Z, Zhang H, Cai X, et al. Luteolin promotes cell apoptosis by inducing autophagy in hepatocellular carcinoma. Cell Physiol Biochem. 2017;43(5):1803\u20131812. doi:10.1159/000484066", "ArticleIdList": ["10.1159/000484066", "29049999"]}, {"Citation": "Wang F, Gao F, Pan S, Zhao S, Xue Y. Luteolin induces apoptosis, G0/G1 cell cycle growth arrest and mitochondrial membrane potential loss in neuroblastoma brain tumor cells. Drug Res. 2015;65(2):91\u201395. doi:10.1055/s-0034-1372648", "ArticleIdList": ["10.1055/s-0034-1372648", "24831243"]}, {"Citation": "Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact. 2006;160(2):123\u2013133. doi:10.1016/j.cbi.2006.01.002", "ArticleIdList": ["10.1016/j.cbi.2006.01.002", "16458870"]}, {"Citation": "Lin D, Kuang G, Wan J, et al. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression. Oncol Rep. 2017;37(2):895\u2013902. doi:10.3892/or.2016.5311", "ArticleIdList": ["10.3892/or.2016.5311", "27959422"]}, {"Citation": "Lin LC, Pai YF, Tsai TH. Isolation of luteolin and luteolin-7-O-glucoside from dendranthema morifolium ramat tzvel and their pharmacokinetics in rats. J Agric Food Chem. 2015;63(35):7700\u20137706. doi:10.1021/jf505848z", "ArticleIdList": ["10.1021/jf505848z", "25625345"]}, {"Citation": "Pardridge WM. CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv. 2016;13(7):963\u2013975. doi:10.1517/17425247.2016.1171315", "ArticleIdList": ["10.1517/17425247.2016.1171315", "27020469"]}, {"Citation": "Patel MM, Patel BM. Crossing the blood-brain barrier: recent advances in drug delivery to the brain. CNS Drugs. 2017;31(2):109\u2013133. doi:10.1007/s40263-016-0405-9", "ArticleIdList": ["10.1007/s40263-016-0405-9", "28101766"]}, {"Citation": "Alyautdin R, Khalin I, Nafeeza MI, Haron MH, Kuznetsov D. Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomedicine. 2014;9:795\u2013811. doi:10.2147/IJN.S52236", "ArticleIdList": ["10.2147/IJN.S52236", "PMC3926460", "24550672"]}, {"Citation": "Larson TA, Joshi PP, Sokolov K. Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. ACS Nano. 2012;6(10):9182\u20139190. doi:10.1021/nn3035155", "ArticleIdList": ["10.1021/nn3035155", "PMC3517292", "23009596"]}, {"Citation": "Lin W, Garnett MC, Schacht E, Davis SS, Illum L. Preparation and in vitro characterization of HSA-mPEG nanoparticles. Int J Pharm. 1999;189(2):161\u2013170.", "ArticleIdList": ["10536244"]}, {"Citation": "Lin W, Garnett MC, Davis SS, Schacht E, Ferruti P, Illum L. Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles. J Controlled Release. 2001;71(1):117\u2013126.", "ArticleIdList": ["11245913"]}, {"Citation": "Sato Y, Sasaki N, Saito M, Endo N, Kugawa F, Ueno A. Luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 human breast cancer cells. Biol Pharm Bull. 2015;38(5):703\u2013709.", "ArticleIdList": ["25947916"]}, {"Citation": "George VC, Naveen Kumar DR, Suresh PK, Kumar S, Kumar RA. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev. 2013;14(2):631\u2013637.", "ArticleIdList": ["23621210"]}, {"Citation": "Fang J, Zhou Q, Shi XL, Jiang BH. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis. 2007;28(3):713\u2013723.", "ArticleIdList": ["17065200"]}, {"Citation": "Kazemi M, Carrer A, Moimas S, et al. VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans. Cancer Gene Ther. 2016;23(5):125\u2013132.", "ArticleIdList": ["27033458"]}, {"Citation": "Swierczak A, Mouchemore KA, Hamilton JA, Anderson RL. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis Rev. 2015;34(4):735\u2013751.", "ArticleIdList": ["26361774"]}]}], "History": [{"Year": "2019", "Month": "5", "Day": "6"}, {"Year": "2019", "Month": "7", "Day": "6"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["31571861", "PMC6754621", "10.2147/IJN.S214585", "214585"]}}]}